Inferior Vena Cava Filters (IVCF) – Pipeline Review, 2015

◆상품코드 : GDME0022EPD
◆발행일 : 2015년 6월
◆페이지수 : 35
◆보고서 형식 : PDF / 영문
◆납품 방식 : Email
◆조사대상 지역 : Global
◆발행회사(조사회사) : GlobalData
◆판매회사 : H&I글로벌리서치(주)
◆판매가격 옵션
Single User¥275,000 -> 환산 ₩2,750,000견적의뢰/구매/질문FORM
Site License¥550,000 -> 환산 ₩5,500,000견적의뢰/구매/질문FORM
Enterprisewide License¥825,000 -> 환산 ₩8,250,000견적의뢰/구매/질문FORM
※지불하실 금액은 상기금액이며, 세금 및 배송료는 없습니다.
※지불은 선불결제 방식이며, 신용카드결제 또는 계좌입금(국내/해외)이 선택가능합니다.
※구매의사를 FORM기입 또는 E메일로 연락주시면 담당자가 회신 드리겠습니다.
※배송은 입금 확인 후, E메일로 납품드리며, 일반적으로 당일~2일정도 소요됩니다.
※가격옵션 설명 : (Single User : 귀사내에서 1명만 사용가능 / Five User, Multi User : 귀사내에서 5명까지 사용가능 / Site License, Corporate License : 동일국내에서 인원제한없이 사용가능 / Global Site License, Enterprise License : 지역상관없이 인원제한없이 사용/공유 가능한 라이센스). 자세한 설명은 이용안내 페이지를 참고하세요.


[조사보고서 개요]

Inferior Vena Cava Filters (IVCF) – Pipeline Review, 2015

Summary

GlobalData’s Medical Devices sector report, “Inferior Vena Cava Filters (IVCF) – Pipeline Review, 2015″ provides an overview of Inferior Vena Cava Filters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Inferior Vena Cava Filters (IVCF) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Inferior Vena Cava Filters (IVCF) products under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Inferior Vena Cava Filters (IVCF) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Inferior Vena Cava Filters (IVCF) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

[조사보고서 목차]

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 Inferior Vena Cava Filters (IVCF) Overview 5
3 Products under Development 6
3.1 Inferior Vena Cava Filters (IVCF) – Pipeline Products by Stage of Development 6
3.2 Inferior Vena Cava Filters (IVCF) – Pipeline Products by Segment 7
3.3 Inferior Vena Cava Filters (IVCF) – Pipeline Products by Territory 8
3.4 Inferior Vena Cava Filters (IVCF) – Pipeline Products by Regulatory Path 9
3.5 Inferior Vena Cava Filters (IVCF) – Pipeline Products by Estimated Approval Date 10
3.6 Inferior Vena Cava Filters (IVCF) – Ongoing Clinical Trials 11
4 Inferior Vena Cava Filters (IVCF) – Pipeline Products under Development by Companies 12
4.1 Inferior Vena Cava Filters (IVCF) Companies – Pipeline Products by Stage of Development 12
4.2 Inferior Vena Cava Filters (IVCF) – Pipeline Products by Stage of Development 13
5 Inferior Vena Cava Filters (IVCF) Companies and Product Overview 14
5.1 Adient Medical Inc. Company Overview 14
5.1.1 Adient Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Bio2 Medical, Inc. Company Overview 15
5.2.1 Bio2 Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Contego Medical, LLC Company Overview 19
5.3.1 Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 19
5.4 Lifetech Scientific (Shenzhen) Co., Ltd. Company Overview 20
5.4.1 Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 20
5.5 NOvate Medical Technologies Company Overview 21
5.5.1 NOvate Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview 21
5.6 Veniti, Inc. Company Overview 24
5.6.1 Veniti, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.7 Volcano Corporation Company Overview 25
5.7.1 Volcano Corporation Pipeline Products & Ongoing Clinical Trials Overview 25
5.8 VueKlar Cardiovascular Ltd. Company Overview 29
5.8.1 VueKlar Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 29
6 Inferior Vena Cava Filters (IVCF)- Recent Developments 30
7 Appendix 33
7.1 Methodology 33
7.2 About GlobalData 35
7.3 Contact Us 35
7.4 Disclaimer 35

1.1 List of Tables
Table 1: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Stage of Development 6
Table 2: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Segment 7
Table 3: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Territory 8
Table 4: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Regulatory Path 9
Table 5: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Estimated Approval Date 10
Table 6: Inferior Vena Cava Filters (IVCF) - Ongoing Clinical Trials 11
Table 7: Inferior Vena Cava Filters (IVCF) Companies - Pipeline Products by Stage of Development 12
Table 8: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Stage of Development 13
Table 9: Adient Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 14
Table 10: Absorbable Vascular Filter - Product Status 14
Table 11: Absorbable Vascular Filter - Product Description 14
Table 12: Bio2 Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 13: Angel Catheter - Product Status 15
Table 14: Angel Catheter - Product Description 16
Table 15: Bio2 Medical, Inc. - Ongoing Clinical Trials Overview 17
Table 16: Angel Catheter - A Multi-center, Early Feasibility Study Of The Angel Catheter In Critically Ill Subjects At High Risk Of Pulmonary Embolism 18
Table 17: Angel Catheter - The Angel Catheter Clinical Trial: Prevention of Pulmonary Embolism in High Risk Subjects 18
Table 18: Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 19
Table 19: Temporary IVC Filter - Product Status 19
Table 20: Temporary IVC Filter - Product Description 19
Table 21: Lifetech Scientific (Shenzhen) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 20
Table 22: Second Generation Vena Cava Filter - Product Status 20
Table 23: Second Generation Vena Cava Filter - Product Description 20
Table 24: NOvate Medical Technologies Pipeline Products & Ongoing Clinical Trials Overview 21
Table 25: Sentry Bio-convertible Filter - Product Status 21
Table 26: Sentry Bio-convertible Filter - Product Description 21
Table 27: NOvate Medical Technologies - Ongoing Clinical Trials Overview 22
Table 28: Sentry Bio-convertible Filter - A Prospective, Multi-center Study of the Novate Sentry Bioconvertible Vena Cava Filter 23
Table 29: Veniti, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 30: VENITI VIDI Vena Cava Filter - Product Status 24
Table 31: VENITI VIDI Vena Cava Filter - Product Description 24
Table 32: Volcano Corporation Pipeline Products & Ongoing Clinical Trials Overview 25
Table 33: Lumifi - Crux + IVUS Combo - Product Status 25
Table 34: Lumifi - Crux + IVUS Combo - Product Description 26
Table 35: Volcano Corporation - Ongoing Clinical Trials Overview 27
Table 36: Lumifi - Crux + IVUS Combo - Evaluation of the Technical Success of Intravascular Ultrasound (IVUS) Guided Vena Cava Filter (VCF) Placement Using the LUMIFI with Crux VCF System (LUMIFI Clinical Study) 28
Table 37: VueKlar Cardiovascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 29
Table 38: MR-Enhancing Retrievable Vena Cava Filter - Product Status 29
Table 39: MR-Enhancing Retrievable Vena Cava Filter - Product Description 29
Table 40: Glossary 34

1.2 List of Figures
Figure 1: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Stage of Development 6
Figure 2: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Segment 7
Figure 3: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Territory 8
Figure 4: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Regulatory Path 9
Figure 5: Inferior Vena Cava Filters (IVCF) - Pipeline Products by Estimated Approval Date 10
Figure 6: Inferior Vena Cava Filters (IVCF) - Ongoing Clinical Trials 11

[조사보고서에 언급된 기업]
Adient Medical Inc.
Bio2 Medical, Inc.
Contego Medical, LLC
Lifetech Scientific (Shenzhen) Co., Ltd.
NOvate Medical Technologies
Veniti, Inc.
Volcano Corporation
VueKlar Cardiovascular Ltd.

[면책사항]
http://www.globalresearch.kr/disclaimer

★조사보고서 [Inferior Vena Cava Filters (IVCF) – Pipeline Review, 2015]에 관해서 E메일 문의 연락
◆H&I글로벌리서치의 고객기업(예)◆